European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

BioNTech Delivery Technologies GmbH, Halle (Saale), Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

BioNTech Delivery Technologies GmbH
BioNTech Protein Therapeutics GmbH
Tulip GmbH

Identification

Ut
District Court of Stendal HRB 28048
Ut
District Court of Mainz HRB 42062
EUID
DEW1215.HRB28048

Address

Weinbergweg 23, 06120 Halle (Saale), Germany
Mainz, Germany

Corporate purpose

Doe transfection of nucleic acids, including the research, development, manufacture and distribution, trade and licensing of transfection reagents or modified nucleic acids.

Financials

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Marketing & Tech

Network

Loading network
tax haven banner

Publications

2 Jun 2025 via BioNTech SE
Shareholder: BioNTech SE
2 Apr 2025
No longer Managing Director: Steffen Panzner
3 Feb 2025
Managing Director: Sierk Pötting · Authorized signatory (ppa): Dennis Oliver Ball
6 Jun 2024 via BioNTech SE
Shareholder: BioNTech SE
6 Jun 2024 via BioNTech SE
Shareholder: BioNTech SE
25 Jan 2024
Authorized signatory (ppa): Dirk Schreiber, Lynn Miriam Voigt · No longer Authorized signatory (ppa) (3)
21 Dec 2023
Patent: Composition
6 Oct 2023
Wordmark: “lipocalyx“
6 Oct 2023
Wordmark: “viromer“
10 May 2023 via BioNTech SE
Shareholder: BioNTech SE
10 May 2023 via BioNTech SE
Shareholder: BioNTech SE
22 Apr 2022 via BioNTech SE
Shareholder: BioNTech SE
20 Apr 2022
Patent: Hydroxylated Polyamine Derivatives AS Transfection Reagents
11 Apr 2022
Patent: RNA Compositions Comprising a Buffer Substance and Methods for Preparing, Storing and Using the Same
15 Dec 2021
Patent: Carboxylated Polyamine Derivatives AS Transfection Reagents
6 Oct 2021
Patent: Carboxylated 2'-Amino-LNA Nucleotides and Oligonucleotides Comprising the Same
3 May 2021 via BioNTech SE
Shareholder: BioNTech SE
27 Apr 2021 via BioNTech SE
Shareholder: BioNTech SE
9 Jun 2020 via BioNTech SE
Shareholder: BioNTech SE
27 May 2020 via BioNTech SE
Shareholder: BioNTech SE
4 Mar 2020
Original document: “Gesellschaftsvertrag / Satzung / Statut“
17 Feb 2020 as BioNTech Protein Therapeutics GmbH
Change of headquarters: BioNTech Delivery Technologies GmbH · Address · Seat: Halle (Saale), Germany
16 Feb 2020
MD: Steffen Panzner, Sierk Poetting, Ugur Sahin · ppa (3) · Control: BioNTech AG, BioNTech SE · Control: BioNTech AG, BioNTech SE · Change of headquarters: BioNTech Protein Therapeutics GmbH · Address
29 Jan 2020 via BioNTech SE
Shareholder: BioNTech SE
9 Jan 2020
Wordmark: “Tulip“
2 Jan 2020 via BioNTech SE
Shareholder: BioNTech SE
20 May 2019 as BioNTech Protein Therapeutics GmbH
Authorized signatory (ppa) (3)
21 Feb 2019 via BioNTech AG
Shareholder: BioNTech AG
14 Feb 2019 via BioNTech AG
Shareholder: BioNTech AG
25 Jun 2018 as BioNTech Protein Therapeutics GmbH
Wordmark: “Tulip“
5 Jun 2018 via BioNTech AG
Shareholder: BioNTech AG
9 May 2018
Patent: Tumor Vaccination Involving a Humoral Immune Response Against Self-Protein Cldn18.2
28 Feb 2018 via BioNTech AG
Shareholder: BioNTech AG
7 Feb 2018 via BioNTech AG
Shareholder: BioNTech AG
6 Feb 2018 via BioNTech AG
Shareholder: BioNTech AG
11 Aug 2017
Patent: Carboxylated 2'-Amino-LNA Nucleotides and Oligonucleotides Comprising the Same
13 Jun 2017 as BioNTech Protein Therapeutics GmbH
Wordmark: “Tulip“
31 May 2017 as BioNTech Protein Therapeutics GmbH
Managing Director: Sierk Poetting, Ugur Sahin
27 Jan 2017 via BioNTech AG
Shareholder: BioNTech AG
26 Jan 2017 via BioNTech AG
Shareholder: BioNTech AG
8 Nov 2016 via BioNTech AG
Shareholder: BioNTech AG
28 Oct 2016 via BioNTech AG
Shareholder: BioNTech AG
1 Jul 2016 via BioNTech AG
Shareholder: BioNTech AG
13 Apr 2016 via BioNTech AG
Shareholder: BioNTech AG
30 Jun 2015 as BioNTech Protein Therapeutics GmbH
Wordmark: “Tulip“
15 Jun 2015 via BioNTech AG
Shareholder: BioNTech AG
5 Mar 2015 via BioNTech AG
Shareholder: BioNTech AG
19 Sept 2014 as BioNTech Protein Therapeutics GmbH
Managing Director: Sierk Poetting · No longer Managing Director (1)
2 Apr 2014
Wordmark: “Tulip“
13 Mar 2014 as BioNTech Protein Therapeutics GmbH
Address · Share­holder agreement · Name: BioNTech Protein Therapeutics GmbH
5 Mar 2014 as BioNTech Protein Therapeutics GmbH
Address · Share­holder agreement · Name: BioNTech Protein Therapeutics GmbH
9 Jan 2014 via BioNTech AG
Shareholder: BioNTech AG
6 Jan 2014 as Tulip GmbH
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012
2 Oct 2013
Patent: Carboxylated Polyamine Derivatives AS Complexes with RNA
2 Oct 2013
Patent: Hydroxylated Polyamine Derivatives AS Transfection Reagents for RNA
16 Jan 2013 as Tulip GmbH
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011
28 Nov 2012 as Tulip GmbH
Managing Director (1)
1 Oct 2012 as BioNTech Protein Therapeutics GmbH
Public funding (€1,458,702): CI3: Production and preclinical validation of a vaccine based on chimary virus-like particles (VLPs) for tumor vaccine, project part Tulip
26 Sept 2011 as Tulip GmbH
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010
16 Mar 2011 as Tulip GmbH
Managing Director: Ugur Sahin
11 Oct 2010 as Tulip GmbH
Managing Director (1)
23 Aug 2010 as Tulip GmbH
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009
9 Aug 2010
Wordmark: “Tulip“
16 Jul 2010 as Tulip GmbH
Address
26 May 2010 as BioNTech Protein Therapeutics GmbH
Wordmark: “Tulip“
2 Feb 2010
Wordmark: “Tulip“
5 Jan 2010 as Tulip GmbH
Control: BioNTech AG · Control: BioNTech AG
28 Dec 2009
Control: BioNTech AG · Control: BioNTech AG
8 Sept 2009 as Tulip GmbH
Control: BioNTech AG · Control: BioNTech AG
20 Aug 2009
Control: BioNTech AG · Control: BioNTech AG
19 Jun 2009 as Tulip GmbH
Reg­is­tra­tion · Managing Director (1) · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
2 Jun 2009 as Tulip GmbH
Reg­is­tra­tion · Managing Director (1) · Address · Capital: €25,000 · Legal form · Name: Tulip GmbH · Corporate Purpose
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "BioNTech Delivery Technologies GmbH, Halle (Saale), Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.